Cargando…
Performance of Different Diagnostic PD-L1 Clones in Head and Neck Squamous Cell Carcinoma
Background: The approval of immune checkpoint inhibitors in combination with specific diagnostic biomarkers presents new challenges to pathologists as tumor tissue needs to be tested for expression of programmed death-ligand 1 (PD-L1) for a variety of indications. As there is currently no requiremen...
Autores principales: | Ribbat-Idel, Julika, Dressler, Franz F., Krupar, Rosemarie, Watermann, Christian, Paulsen, Finn-Ole, Kuppler, Patrick, Klapper, Luise, Offermann, Anne, Wollenberg, Barbara, Rades, Dirk, Laban, Simon, Reischl, Markus, Bruchhage, Karl-Ludwig, Idel, Christian, Perner, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110724/ https://www.ncbi.nlm.nih.gov/pubmed/33987192 http://dx.doi.org/10.3389/fmed.2021.640515 |
Ejemplares similares
-
Immunologic “Cold” Squamous Cell Carcinomas of the Head and Neck Are Associated With an Unfavorable Prognosis
por: Ribbat-Idel, Julika, et al.
Publicado: (2021) -
CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
por: Paulsen, Finn-Ole, et al.
Publicado: (2020) -
NR2F6 as a Prognostic Biomarker in HNSCC
por: Klapper, Luise, et al.
Publicado: (2020) -
Spatial Distribution of Immune Cells in Head and Neck Squamous Cell Carcinomas
por: Idel, Christian, et al.
Publicado: (2021) -
EVI1 as a Marker for Lymph Node Metastasis in HNSCC
por: Idel, Christian, et al.
Publicado: (2020)